by Nathaniel Harding | Feb 12, 2024 | Media
Our Principal, Susan Moring, joined CorriXR CEO, Deborah Moorad and CorriXR’s Founder and CSO, Eric B. Kmiec, in an exclusive interview with OETA. This insightful interview highlights the pioneering efforts this amazing company is making in transforming gene editing...
by Nathaniel Harding | Feb 7, 2024 | Media
We are excited to share an exclusive feature published by Axios on Lumata Health on their Series A+ funding round from 2023. We are proud to have one of our spectacular portfolio companies featured in such a reputable publication, and we look forward to continued...
by Nathaniel Harding | Feb 7, 2024 | Media
This article discusses the impact of the Federal Reserve’s decision not to cut interest rates and its implications for various sectors, including venture capital (VC). The Federal Reserve’s indication that rate cuts are unlikely in the near future has led...
by Nathaniel Harding | Feb 5, 2024 | Blog, Media
Lumata Health: Pioneering Next-Generation Eye Care At Cortado Ventures, we are in the venture capital business of maximizing risk-adjusted returns with high-potential, early-stage startups. We seek transformative technology solutions with as little risk as possible....
by Nathaniel Harding | Jan 22, 2024 | Media
FOR IMMEDIATE RELEASE Jan. 16, 2024 Contact: Anthony Triana atriana@saxum.com (Direct) 405.818.0791 Cortado Ventures Invests in CorriXR: A Groundbreaking Gene-Editing Company with Initial Focus on Oncology OKLAHOMA CITY – Cortado Ventures, a...
by Nathaniel Harding | Jan 19, 2024 | Media
Congratulations to our Managing Partner, Nathaniel Harding for earning another term of service for the Greater Oklahoma City Chamber board. Board members, in roles like this, play a pivotal part in shaping the direction and policies of the organization....
